We are pioneering a new class of medicine we call endobody vaccines that are fully synthetic and train the body to safely and efficiently treat and prevent neurological disease.
We are not afraid to be brave and tackle the seemingly impossible. We are committed to transforming the lives of all patients and families affected by Alzheimer’s, Parkinson’s, CTE and other neurological diseases.
We envision a world where neurodegenerative diseases are prophylactically eradicated.
By The Numbers
80 years ago, it was polio. Today, our epidemic is Alzheimer’s.
CHANCE YOU WILL HAVE ALZHEIMER’S
IF OVER 85 YEARS OLD
ANNUAL COST TO THE WORLD
Just as science brought us a vaccine against polio and virtually eradicated the disease worldwide, we are working to develop vaccines to treat and ultimately prevent Alzheimer’s and other neurological diseases.
We aren’t your average vaccine company.
We have built a robust translational platform to rapidly design and develop targeted immunotherapeutics based on the industry’s leading endobody vaccine technology. After two decades of research and over 3 billion doses commercialized on other indications, we are now developing the world’s most advanced active vaccine against Alzheimer’s.
October 16, 2018 -
United Neuroscience appoints Mariah DeLeon as Vice President of People, Jean-Cosme "JC" Dodart, Ph.D., as Vice President of Preclinical Development, Michael Ma, Ph.D., as Head of Research and Development Operations and Project Management, Suzanne Ostrander as Head of Clinical Operations, and Sharon Tamir as Head of External Alliances.Read More
October 4, 2018 -
The story of Alzheimer’s drug development has been filled with heartbreak over the past few decades. That’s part of the reason why some companies, researchers, and advocacy groups are now trying to prevent the brain-eating disease in the first place rather than curing it after-the-fact. United Neuroscience is one of those companies!Read More